» Articles » PMID: 11529870

Cord Blood Megakaryocytes Do Not Complete Maturation, As Indicated by Impaired Establishment of Endomitosis and Low Expression of G1/S Cyclins Upon Thrombopoietin-induced Differentiation

Overview
Journal Br J Haematol
Specialty Hematology
Date 2001 Sep 1
PMID 11529870
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cord blood (CB) has successfully been used as a stem cell source for haemopoietic reconstitution. However, a significant delay in platelet engraftment is consistently found in CB versus adult peripheral blood (PB) or bone marrow transplants. We sought to determine whether or not CB megakaryocytes have reached terminal maturation and, hence, full thrombopoietic potential. A comparative analysis of megakaryocytes cultured from either CB or PB progenitors in the presence of thrombopoietin (TPO) showed a similar differentiation response, although proliferation was 2.4 times higher in CB than in PB cells. Importantly, the TPO-induced ploidy level was notably different: whereas 82.7% of CB megakaryocytes remained diploid (2N) at the end of the culture, more than 50% of PB megakaryocytes had reached a DNA content equal to or higher than 4N. Western blot and flow cytometry analyses revealed that only polyploid PB megakaryocytes expressed cyclins E, A and B, whereas cyclin D3 was detected in both fetal and adult megakaryocytic nuclei. These data suggest that establishment of endomitotic cycles is impaired in CB megakaryocytes, associated with a differential regulation of G1/S cell cycle factors. We believe that the relative immaturity of fetal megakaryocytes could be a contributing factor to the delayed platelet engraftment in cord blood transplantation.

Citing Articles

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.

Kumar B, Afshar-Kharghan V, Mendt M, Sackstein R, Tanner M, Popat U Front Immunol. 2022; 13:1018047.

PMID: 36203567 PMC: 9530569. DOI: 10.3389/fimmu.2022.1018047.


Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation.

Tang B, Huang L, Liu H, Cheng S, Song K, Zhang X Blood Adv. 2020; 4(16):3829-3839.

PMID: 32790845 PMC: 7448600. DOI: 10.1182/bloodadvances.2020002257.


Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells.

Perdomo J, Yan F, Leung H, Chong B J Vis Exp. 2018; (130).

PMID: 29364213 PMC: 5908394. DOI: 10.3791/56420.


Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations.

Kellner J, Li S, Zweidler-McKay P, Shpall E, McNiece I Cytotherapy. 2014; 17(4):418-27.

PMID: 25532425 PMC: 4357564. DOI: 10.1016/j.jcyt.2014.11.004.


Usefulness of umbilical cord blood cells in era of hematopoiesis research.

Park S, Won J Int J Stem Cells. 2014; 2(2):90-6.

PMID: 24855526 PMC: 4021762. DOI: 10.15283/ijsc.2009.2.2.90.